VivoSeq
Other

Immunology

2

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Immunology is an early-stage landscape with 2 programs across 1 company. The most active players are Sanofi. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2

Nonavalent HPV Vaccine

Xiamen University

Hepatitis a (HAV) Vaccines

Washington University School of Medicine

Analysis

Trial Status

11

clinical trials

Completed6 · 55%
Active, not recruiting3 · 27%
Not yet recruiting1 · 9%
Withdrawn1 · 9%

Clinical Trials

Trial Activity

11 trials

Immunology of Ebola Vaccine
Active, not recruiting·EEmory University·Phase 2·NCT06100913·30 enrolled
Vaccine Pandemic Preparedness Through Airway Immunology Characterization
Active, not recruiting·CCopenhagen Respiratory Research·Phase 1·NCT05921448·60 enrolled
Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines
Active, not recruiting·WWashington University School of Medicine·Approved·NCT07493460·25 enrolled
SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC
Not yet recruiting·—·Phase 2·NCT06925048·86 enrolled
TB Nutrition, Immunology and Epidemiology
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00170404·887 enrolled
Chlamydia Trachomatis Immunology and Vaccinology Study
Completed·—·N/A·NCT01150747·347 enrolled
Immunology of Non-specific Effects of Vaccine
Completed·BBandim Health Project·Phase 4·NCT00168545·400 enrolled
Immunology and Safety of Menactra® in Children in Saudi Arabia
Completed·Sanofi logoSanofi·Phase 3·NCT00539032·238 enrolled
Immunology of the Infection Perinatal
Completed·FFrench National Agency for Research on AIDS and Viral Hepatitis·N/A·NCT01055873·93 enrolled
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT03014310·388 enrolled
SHIFT: Studying HIV Immunology After Fecal Transplant
Withdrawn·MMassachusetts General Hospital·Phase 1/2·NCT03163784

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)